Free Trial
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.36 -0.09 (-19.80%)
As of 02:37 PM Eastern

About Biotricity Stock (NASDAQ:BTCY)

Key Stats

Today's Range
$0.35
$0.42
50-Day Range
$0.25
$0.53
52-Week Range
$0.19
$1.67
Volume
3,208 shs
Average Volume
49,179 shs
Market Capitalization
$8.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

Biotricity (NASDAQ:BTCY) Trading Up 26.2% - Should You Buy?
22x better than Bitcoin… WITHOUT crypto
We’re on the verge of a massive paradigm shift. And it will leave millions of people behind… including you, perhaps. The legendary former hedge fund manager Larry Benedict has discovered a different way to make money from Bitcoin.
H.C. Wainwright Reaffirms Their Hold Rating on Biotricity (BTCY)
Biotricity, Inc. (BTCY) Q2 2025 Earnings Call Transcript
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.2899 on January 1st, 2025. Since then, BTCY shares have increased by 24.6% and is now trading at $0.3612.
View the best growth stocks for 2025 here
.

Biotricity, Inc. (NASDAQ:BTCY) issued its earnings results on Thursday, June, 27th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.36) by $0.11. The business had revenue of $3.18 million for the quarter, compared to the consensus estimate of $3.20 million.

Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include TransDigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL).

Company Calendar

Last Earnings
6/27/2024
Today
1/30/2025
Next Earnings (Estimated)
2/18/2025
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BTCY
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Net Income
$-14,090,000.00
Pretax Margin
-97.04%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Book Value
($3.34) per share

Miscellaneous

Free Float
22,075,000
Market Cap
$8.87 million
Optionable
Optionable
Beta
1.08
Beginners Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:BTCY) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners